Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GERN · against 430 other Healthcare companies of similar size
Ranked #11 of 431 · scores higher than 97% of peers
Bars: peers in each 10-point band of the growth score35 peers with a growth score of 90–100, including GERN · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | GERN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 445 reported | 138.8% | 3.3% | 97% | 33% | |
| Earnings per share growthHigher is better · 225 reported | Not reported | 3.9% | — | — | 33% |
| 3-year revenue growthHigher is better · 423 reported | 575.7% | 3.7% | 99% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 11 | 534.0B KRW (≈$385M) | 96 | 59 | |
| 11 | 377M USD | 96 | 29 | |
| 11 | 500M USD | 96 | 63 | |
| 11 | 660M USD | 96 | 43 | |
| 11 | 598M USD | 96 | 49 | |
| 11 | 334M USD | 96 | 49 | |
| 17 | 4.7B CNY (≈$653M) | 95 | 52 | |
| 17 | 1.1B USD | 95 | 50 | |
| 17 | 467M USD | 95 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score